nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—Cyclopentolate—Diphenhydramine—atopic dermatitis	0.33	1	CrCrCtD
Venlafaxine—CYP2B6—Diphenhydramine—atopic dermatitis	0.0349	0.0793	CbGbCtD
Venlafaxine—ABCG2—Hydrocortisone—atopic dermatitis	0.0276	0.0627	CbGbCtD
Venlafaxine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0246	0.0559	CbGbCtD
Venlafaxine—ABCB1—Tacrolimus—atopic dermatitis	0.0245	0.0555	CbGbCtD
Venlafaxine—CYP2C19—Loratadine—atopic dermatitis	0.0222	0.0504	CbGbCtD
Venlafaxine—CYP2C19—Diphenhydramine—atopic dermatitis	0.0222	0.0504	CbGbCtD
Venlafaxine—CYP2C9—Loratadine—atopic dermatitis	0.0185	0.0419	CbGbCtD
Venlafaxine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0185	0.0419	CbGbCtD
Venlafaxine—ABCB1—Loratadine—atopic dermatitis	0.0179	0.0406	CbGbCtD
Venlafaxine—ABCG2—Dexamethasone—atopic dermatitis	0.0172	0.039	CbGbCtD
Venlafaxine—CYP2D6—Loratadine—atopic dermatitis	0.0169	0.0383	CbGbCtD
Venlafaxine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0169	0.0383	CbGbCtD
Venlafaxine—ABCB1—Methylprednisolone—atopic dermatitis	0.0164	0.0372	CbGbCtD
Venlafaxine—CYP3A4—Tacrolimus—atopic dermatitis	0.0147	0.0333	CbGbCtD
Venlafaxine—CYP2C19—Prednisone—atopic dermatitis	0.0123	0.0279	CbGbCtD
Venlafaxine—CYP2B6—Dexamethasone—atopic dermatitis	0.0121	0.0274	CbGbCtD
Venlafaxine—CYP3A4—Loratadine—atopic dermatitis	0.0107	0.0244	CbGbCtD
Venlafaxine—ABCB1—Betamethasone—atopic dermatitis	0.0106	0.0242	CbGbCtD
Venlafaxine—ABCB1—Prednisolone—atopic dermatitis	0.0105	0.0238	CbGbCtD
Venlafaxine—ABCB1—Hydrocortisone—atopic dermatitis	0.00996	0.0226	CbGbCtD
Venlafaxine—ABCB1—Prednisone—atopic dermatitis	0.00992	0.0225	CbGbCtD
Venlafaxine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00981	0.0223	CbGbCtD
Venlafaxine—CYP2C19—Dexamethasone—atopic dermatitis	0.00768	0.0174	CbGbCtD
Venlafaxine—CYP3A4—Triamcinolone—atopic dermatitis	0.00744	0.0169	CbGbCtD
Venlafaxine—CYP2C9—Dexamethasone—atopic dermatitis	0.00638	0.0145	CbGbCtD
Venlafaxine—CYP3A4—Betamethasone—atopic dermatitis	0.00638	0.0145	CbGbCtD
Venlafaxine—CYP3A4—Prednisolone—atopic dermatitis	0.0063	0.0143	CbGbCtD
Venlafaxine—ABCB1—Dexamethasone—atopic dermatitis	0.00619	0.0141	CbGbCtD
Venlafaxine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00597	0.0135	CbGbCtD
Venlafaxine—CYP3A4—Prednisone—atopic dermatitis	0.00595	0.0135	CbGbCtD
Venlafaxine—CYP2D6—Dexamethasone—atopic dermatitis	0.00584	0.0132	CbGbCtD
Venlafaxine—CYP3A4—Dexamethasone—atopic dermatitis	0.00371	0.00842	CbGbCtD
Venlafaxine—NPY1R—Peptide GPCRs—CCR3—atopic dermatitis	0.000527	0.0335	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000472	0.03	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide GPCRs—CXCR3—atopic dermatitis	0.000461	0.0293	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000421	0.0268	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000377	0.024	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000355	0.0226	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000316	0.0201	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000304	0.0193	CbGpPWpGaD
Venlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—atopic dermatitis	0.000302	0.0192	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide GPCRs—CCR5—atopic dermatitis	0.000289	0.0184	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000282	0.0179	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000253	0.0161	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000248	0.0158	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL22—atopic dermatitis	0.000241	0.0153	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—RELB—atopic dermatitis	0.000233	0.0148	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000221	0.0141	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000221	0.0141	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000217	0.0138	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL27—atopic dermatitis	0.000215	0.0137	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000209	0.0133	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000204	0.013	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000194	0.0123	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL17—atopic dermatitis	0.000193	0.0123	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000183	0.0116	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000175	0.0111	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00017	0.0108	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000166	0.0106	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL11—atopic dermatitis	0.000155	0.00988	CbGpPWpGaD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000155	0.00987	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000151	0.00959	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000148	0.00943	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000148	0.00943	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000148	0.0094	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000145	0.00924	CbGpPWpGaD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—atopic dermatitis	0.000137	0.00874	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000136	0.00864	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—IL1B—atopic dermatitis	0.000128	0.00817	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000127	0.00809	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCR3—atopic dermatitis	0.000127	0.00805	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL22—atopic dermatitis	0.000124	0.00787	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CCL27—atopic dermatitis	0.000121	0.00772	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000117	0.00747	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000115	0.00729	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—NPS—atopic dermatitis	0.000113	0.00718	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—TAC1—atopic dermatitis	0.000113	0.00718	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCR3—atopic dermatitis	0.000111	0.00704	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—IL1B—atopic dermatitis	0.00011	0.00702	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL27—atopic dermatitis	0.00011	0.00701	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.00011	0.00701	CbGpPWpGaD
Venlafaxine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000106	0.00676	CbGpPWpGaD
Venlafaxine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000104	0.0066	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.000101	0.00645	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000101	0.00643	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL17—atopic dermatitis	9.89e-05	0.00629	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—IL1B—atopic dermatitis	9.78e-05	0.00622	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	9.76e-05	0.00621	CbGpPWpGaD
Venlafaxine—SLC6A4—Monoamine Transport—TNF—atopic dermatitis	9.31e-05	0.00592	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.11e-05	0.0058	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL10—atopic dermatitis	8.94e-05	0.00569	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	8.64e-05	0.0055	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	8.4e-05	0.00535	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—NPS—atopic dermatitis	8.28e-05	0.00527	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	8.21e-05	0.00522	CbGpPWpGaD
Venlafaxine—SLC6A2—Monoamine Transport—TNF—atopic dermatitis	8.01e-05	0.00509	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCL11—atopic dermatitis	7.97e-05	0.00507	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	7.95e-05	0.00506	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—FCER2—atopic dermatitis	7.86e-05	0.005	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCL5—atopic dermatitis	7.7e-05	0.0049	CbGpPWpGaD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	7.65e-05	0.00487	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL22—atopic dermatitis	7.31e-05	0.00465	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	7.22e-05	0.00459	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL13—atopic dermatitis	7.19e-05	0.00457	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR3—atopic dermatitis	7.15e-05	0.00455	CbGpPWpGaD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	7.15e-05	0.00455	CbGpPWpGaD
Venlafaxine—SLC6A3—Monoamine Transport—TNF—atopic dermatitis	7.09e-05	0.00451	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	7.05e-05	0.00448	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—CCR5—atopic dermatitis	6.94e-05	0.00441	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.93e-05	0.00441	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—atopic dermatitis	6.89e-05	0.00438	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	6.62e-05	0.00421	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL27—atopic dermatitis	6.51e-05	0.00414	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CCR3—atopic dermatitis	6.5e-05	0.00413	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—NGF—atopic dermatitis	6.41e-05	0.00408	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—TAC1—atopic dermatitis	6.38e-05	0.00406	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—NPS—atopic dermatitis	6.38e-05	0.00406	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCR3—atopic dermatitis	6.25e-05	0.00398	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	6.24e-05	0.00397	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—IL5—atopic dermatitis	6.15e-05	0.00391	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—IL5—atopic dermatitis	5.93e-05	0.00377	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL17—atopic dermatitis	5.84e-05	0.00372	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—TAC1—atopic dermatitis	5.79e-05	0.00368	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—NPS—atopic dermatitis	5.79e-05	0.00368	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCR3—atopic dermatitis	5.68e-05	0.00361	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.51e-05	0.0035	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL5—atopic dermatitis	5.38e-05	0.00342	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KIF3A—atopic dermatitis	5.21e-05	0.00331	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL10—atopic dermatitis	5.05e-05	0.00322	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—PPARA—atopic dermatitis	4.88e-05	0.0031	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.72e-05	0.003	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCL11—atopic dermatitis	4.71e-05	0.003	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CMA1—atopic dermatitis	4.71e-05	0.003	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL10—atopic dermatitis	4.59e-05	0.00292	CbGpPWpGaD
Venlafaxine—Syncope—Triamcinolone—atopic dermatitis	4.53e-05	0.000212	CcSEcCtD
Venlafaxine—Vertigo—Methylprednisolone—atopic dermatitis	4.53e-05	0.000212	CcSEcCtD
Venlafaxine—Syncope—Methylprednisolone—atopic dermatitis	4.52e-05	0.000212	CcSEcCtD
Venlafaxine—Discomfort—Hydrocortisone—atopic dermatitis	4.51e-05	0.000211	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	4.5e-05	0.00286	CbGpPWpGaD
Venlafaxine—Anaphylactic shock—Prednisolone—atopic dermatitis	4.49e-05	0.00021	CcSEcCtD
Venlafaxine—Oedema—Prednisolone—atopic dermatitis	4.49e-05	0.00021	CcSEcCtD
Venlafaxine—Vomiting—Tacrolimus—atopic dermatitis	4.46e-05	0.000209	CcSEcCtD
Venlafaxine—Loss of consciousness—Triamcinolone—atopic dermatitis	4.44e-05	0.000208	CcSEcCtD
Venlafaxine—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.43e-05	0.000208	CcSEcCtD
Venlafaxine—Rash—Tacrolimus—atopic dermatitis	4.43e-05	0.000207	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—STAT6—atopic dermatitis	4.43e-05	0.00282	CbGpPWpGaD
Venlafaxine—Dermatitis—Tacrolimus—atopic dermatitis	4.42e-05	0.000207	CcSEcCtD
Venlafaxine—Shock—Prednisolone—atopic dermatitis	4.41e-05	0.000207	CcSEcCtD
Venlafaxine—Cough—Triamcinolone—atopic dermatitis	4.41e-05	0.000207	CcSEcCtD
Venlafaxine—Headache—Tacrolimus—atopic dermatitis	4.4e-05	0.000206	CcSEcCtD
Venlafaxine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	4.38e-05	0.000205	CcSEcCtD
Venlafaxine—Oedema—Hydrocortisone—atopic dermatitis	4.38e-05	0.000205	CcSEcCtD
Venlafaxine—Convulsion—Triamcinolone—atopic dermatitis	4.38e-05	0.000205	CcSEcCtD
Venlafaxine—Tachycardia—Prednisolone—atopic dermatitis	4.38e-05	0.000205	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	4.37e-05	0.00278	CbGpPWpGaD
Venlafaxine—Convulsion—Methylprednisolone—atopic dermatitis	4.37e-05	0.000205	CcSEcCtD
Venlafaxine—Hypertension—Triamcinolone—atopic dermatitis	4.36e-05	0.000204	CcSEcCtD
Venlafaxine—Hypertension—Methylprednisolone—atopic dermatitis	4.35e-05	0.000204	CcSEcCtD
Venlafaxine—Infection—Hydrocortisone—atopic dermatitis	4.35e-05	0.000204	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCL5—atopic dermatitis	4.35e-05	0.00277	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Prednisolone—atopic dermatitis	4.34e-05	0.000203	CcSEcCtD
Venlafaxine—Shock—Hydrocortisone—atopic dermatitis	4.31e-05	0.000202	CcSEcCtD
Venlafaxine—Myalgia—Triamcinolone—atopic dermatitis	4.3e-05	0.000202	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	4.3e-05	0.00273	CbGpPWpGaD
Venlafaxine—Myalgia—Methylprednisolone—atopic dermatitis	4.29e-05	0.000201	CcSEcCtD
Venlafaxine—Arthralgia—Methylprednisolone—atopic dermatitis	4.29e-05	0.000201	CcSEcCtD
Venlafaxine—Anxiety—Methylprednisolone—atopic dermatitis	4.28e-05	0.0002	CcSEcCtD
Venlafaxine—Tachycardia—Hydrocortisone—atopic dermatitis	4.28e-05	0.0002	CcSEcCtD
Venlafaxine—Flushing—Prednisone—atopic dermatitis	4.26e-05	0.000199	CcSEcCtD
Venlafaxine—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.25e-05	0.000199	CcSEcCtD
Venlafaxine—Ill-defined disorder—Betamethasone—atopic dermatitis	4.25e-05	0.000199	CcSEcCtD
Venlafaxine—Discomfort—Triamcinolone—atopic dermatitis	4.25e-05	0.000199	CcSEcCtD
Venlafaxine—Discomfort—Methylprednisolone—atopic dermatitis	4.24e-05	0.000199	CcSEcCtD
Venlafaxine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.23e-05	0.000198	CcSEcCtD
Venlafaxine—Dry mouth—Triamcinolone—atopic dermatitis	4.21e-05	0.000197	CcSEcCtD
Venlafaxine—NPY1R—GPCR ligand binding—CXCL8—atopic dermatitis	4.19e-05	0.00267	CbGpPWpGaD
Venlafaxine—Angioedema—Betamethasone—atopic dermatitis	4.19e-05	0.000196	CcSEcCtD
Venlafaxine—Angioedema—Dexamethasone—atopic dermatitis	4.19e-05	0.000196	CcSEcCtD
Venlafaxine—Anorexia—Hydrocortisone—atopic dermatitis	4.18e-05	0.000196	CcSEcCtD
Venlafaxine—Nausea—Tacrolimus—atopic dermatitis	4.17e-05	0.000195	CcSEcCtD
Venlafaxine—Confusional state—Methylprednisolone—atopic dermatitis	4.15e-05	0.000194	CcSEcCtD
Venlafaxine—Malaise—Dexamethasone—atopic dermatitis	4.14e-05	0.000194	CcSEcCtD
Venlafaxine—Malaise—Betamethasone—atopic dermatitis	4.14e-05	0.000194	CcSEcCtD
Venlafaxine—Oedema—Triamcinolone—atopic dermatitis	4.12e-05	0.000193	CcSEcCtD
Venlafaxine—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.12e-05	0.000193	CcSEcCtD
Venlafaxine—Vertigo—Betamethasone—atopic dermatitis	4.12e-05	0.000193	CcSEcCtD
Venlafaxine—Vertigo—Dexamethasone—atopic dermatitis	4.12e-05	0.000193	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.12e-05	0.000193	CcSEcCtD
Venlafaxine—Syncope—Dexamethasone—atopic dermatitis	4.11e-05	0.000193	CcSEcCtD
Venlafaxine—Syncope—Betamethasone—atopic dermatitis	4.11e-05	0.000193	CcSEcCtD
Venlafaxine—Arrhythmia—Prednisone—atopic dermatitis	4.1e-05	0.000192	CcSEcCtD
Venlafaxine—Infection—Triamcinolone—atopic dermatitis	4.1e-05	0.000192	CcSEcCtD
Venlafaxine—Hypotension—Hydrocortisone—atopic dermatitis	4.09e-05	0.000192	CcSEcCtD
Venlafaxine—Infection—Methylprednisolone—atopic dermatitis	4.09e-05	0.000192	CcSEcCtD
Venlafaxine—Shock—Triamcinolone—atopic dermatitis	4.06e-05	0.00019	CcSEcCtD
Venlafaxine—Insomnia—Prednisolone—atopic dermatitis	4.06e-05	0.00019	CcSEcCtD
Venlafaxine—Alopecia—Prednisone—atopic dermatitis	4.05e-05	0.00019	CcSEcCtD
Venlafaxine—Shock—Methylprednisolone—atopic dermatitis	4.05e-05	0.00019	CcSEcCtD
Venlafaxine—Loss of consciousness—Dexamethasone—atopic dermatitis	4.03e-05	0.000189	CcSEcCtD
Venlafaxine—Loss of consciousness—Betamethasone—atopic dermatitis	4.03e-05	0.000189	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisolone—atopic dermatitis	4.03e-05	0.000189	CcSEcCtD
Venlafaxine—Tachycardia—Triamcinolone—atopic dermatitis	4.03e-05	0.000189	CcSEcCtD
Venlafaxine—Tachycardia—Methylprednisolone—atopic dermatitis	4.02e-05	0.000188	CcSEcCtD
Venlafaxine—Erythema—Prednisone—atopic dermatitis	3.99e-05	0.000187	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	3.99e-05	0.000187	CcSEcCtD
Venlafaxine—Hyperhidrosis—Triamcinolone—atopic dermatitis	3.99e-05	0.000187	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	3.98e-05	0.000186	CcSEcCtD
Venlafaxine—Convulsion—Betamethasone—atopic dermatitis	3.97e-05	0.000186	CcSEcCtD
Venlafaxine—Convulsion—Dexamethasone—atopic dermatitis	3.97e-05	0.000186	CcSEcCtD
Venlafaxine—Insomnia—Hydrocortisone—atopic dermatitis	3.96e-05	0.000186	CcSEcCtD
Venlafaxine—Hypertension—Dexamethasone—atopic dermatitis	3.96e-05	0.000185	CcSEcCtD
Venlafaxine—Hypertension—Betamethasone—atopic dermatitis	3.96e-05	0.000185	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCL5—atopic dermatitis	3.95e-05	0.00251	CbGpPWpGaD
Venlafaxine—Paraesthesia—Hydrocortisone—atopic dermatitis	3.93e-05	0.000184	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CCR5—atopic dermatitis	3.92e-05	0.00249	CbGpPWpGaD
Venlafaxine—Myalgia—Dexamethasone—atopic dermatitis	3.9e-05	0.000183	CcSEcCtD
Venlafaxine—Myalgia—Betamethasone—atopic dermatitis	3.9e-05	0.000183	CcSEcCtD
Venlafaxine—Anxiety—Dexamethasone—atopic dermatitis	3.89e-05	0.000182	CcSEcCtD
Venlafaxine—Anxiety—Betamethasone—atopic dermatitis	3.89e-05	0.000182	CcSEcCtD
Venlafaxine—Discomfort—Dexamethasone—atopic dermatitis	3.86e-05	0.000181	CcSEcCtD
Venlafaxine—Discomfort—Betamethasone—atopic dermatitis	3.86e-05	0.000181	CcSEcCtD
Venlafaxine—Dyspepsia—Hydrocortisone—atopic dermatitis	3.86e-05	0.000181	CcSEcCtD
Venlafaxine—Hypotension—Methylprednisolone—atopic dermatitis	3.85e-05	0.00018	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCR3—atopic dermatitis	3.84e-05	0.00244	CbGpPWpGaD
Venlafaxine—Pain—Prednisolone—atopic dermatitis	3.84e-05	0.00018	CcSEcCtD
Venlafaxine—Decreased appetite—Hydrocortisone—atopic dermatitis	3.81e-05	0.000178	CcSEcCtD
Venlafaxine—Fatigue—Hydrocortisone—atopic dermatitis	3.78e-05	0.000177	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	3.77e-05	0.0024	CbGpPWpGaD
Venlafaxine—Vision blurred—Prednisone—atopic dermatitis	3.76e-05	0.000176	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	3.76e-05	0.000176	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	3.75e-05	0.000176	CcSEcCtD
Venlafaxine—Pain—Hydrocortisone—atopic dermatitis	3.75e-05	0.000175	CcSEcCtD
Venlafaxine—Oedema—Dexamethasone—atopic dermatitis	3.74e-05	0.000175	CcSEcCtD
Venlafaxine—Oedema—Betamethasone—atopic dermatitis	3.74e-05	0.000175	CcSEcCtD
Venlafaxine—Anaphylactic shock—Dexamethasone—atopic dermatitis	3.74e-05	0.000175	CcSEcCtD
Venlafaxine—Anaphylactic shock—Betamethasone—atopic dermatitis	3.74e-05	0.000175	CcSEcCtD
Venlafaxine—Insomnia—Triamcinolone—atopic dermatitis	3.73e-05	0.000175	CcSEcCtD
Venlafaxine—Insomnia—Methylprednisolone—atopic dermatitis	3.72e-05	0.000174	CcSEcCtD
Venlafaxine—Infection—Dexamethasone—atopic dermatitis	3.72e-05	0.000174	CcSEcCtD
Venlafaxine—Infection—Betamethasone—atopic dermatitis	3.72e-05	0.000174	CcSEcCtD
Venlafaxine—Ill-defined disorder—Prednisone—atopic dermatitis	3.71e-05	0.000174	CcSEcCtD
Venlafaxine—Paraesthesia—Triamcinolone—atopic dermatitis	3.7e-05	0.000173	CcSEcCtD
Venlafaxine—Feeling abnormal—Prednisolone—atopic dermatitis	3.7e-05	0.000173	CcSEcCtD
Venlafaxine—Paraesthesia—Methylprednisolone—atopic dermatitis	3.7e-05	0.000173	CcSEcCtD
Venlafaxine—Anaemia—Prednisone—atopic dermatitis	3.69e-05	0.000173	CcSEcCtD
Venlafaxine—Shock—Betamethasone—atopic dermatitis	3.68e-05	0.000172	CcSEcCtD
Venlafaxine—Shock—Dexamethasone—atopic dermatitis	3.68e-05	0.000172	CcSEcCtD
Venlafaxine—Dyspnoea—Triamcinolone—atopic dermatitis	3.68e-05	0.000172	CcSEcCtD
Venlafaxine—Agitation—Prednisone—atopic dermatitis	3.67e-05	0.000172	CcSEcCtD
Venlafaxine—Thrombocytopenia—Dexamethasone—atopic dermatitis	3.66e-05	0.000172	CcSEcCtD
Venlafaxine—Thrombocytopenia—Betamethasone—atopic dermatitis	3.66e-05	0.000172	CcSEcCtD
Venlafaxine—Tachycardia—Dexamethasone—atopic dermatitis	3.65e-05	0.000171	CcSEcCtD
Venlafaxine—Tachycardia—Betamethasone—atopic dermatitis	3.65e-05	0.000171	CcSEcCtD
Venlafaxine—Angioedema—Prednisone—atopic dermatitis	3.65e-05	0.000171	CcSEcCtD
Venlafaxine—Dyspepsia—Triamcinolone—atopic dermatitis	3.63e-05	0.00017	CcSEcCtD
Venlafaxine—Dyspepsia—Methylprednisolone—atopic dermatitis	3.62e-05	0.00017	CcSEcCtD
Venlafaxine—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.62e-05	0.000169	CcSEcCtD
Venlafaxine—Hyperhidrosis—Betamethasone—atopic dermatitis	3.62e-05	0.000169	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	3.61e-05	0.0023	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.61e-05	0.000169	CcSEcCtD
Venlafaxine—Malaise—Prednisone—atopic dermatitis	3.6e-05	0.000169	CcSEcCtD
Venlafaxine—Vertigo—Prednisone—atopic dermatitis	3.59e-05	0.000168	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.58e-05	0.000168	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.58e-05	0.00228	CbGpPWpGaD
Venlafaxine—Syncope—Prednisone—atopic dermatitis	3.58e-05	0.000168	CcSEcCtD
Venlafaxine—Anorexia—Betamethasone—atopic dermatitis	3.57e-05	0.000167	CcSEcCtD
Venlafaxine—Anorexia—Dexamethasone—atopic dermatitis	3.57e-05	0.000167	CcSEcCtD
Venlafaxine—Urticaria—Prednisolone—atopic dermatitis	3.56e-05	0.000167	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CCR5—atopic dermatitis	3.56e-05	0.00226	CbGpPWpGaD
Venlafaxine—Fatigue—Triamcinolone—atopic dermatitis	3.56e-05	0.000167	CcSEcCtD
Venlafaxine—Fatigue—Methylprednisolone—atopic dermatitis	3.55e-05	0.000166	CcSEcCtD
Venlafaxine—Pain—Triamcinolone—atopic dermatitis	3.53e-05	0.000165	CcSEcCtD
Venlafaxine—Loss of consciousness—Prednisone—atopic dermatitis	3.51e-05	0.000164	CcSEcCtD
Venlafaxine—Hypotension—Dexamethasone—atopic dermatitis	3.5e-05	0.000164	CcSEcCtD
Venlafaxine—Hypotension—Betamethasone—atopic dermatitis	3.5e-05	0.000164	CcSEcCtD
Venlafaxine—Urticaria—Hydrocortisone—atopic dermatitis	3.48e-05	0.000163	CcSEcCtD
Venlafaxine—Abdominal pain—Hydrocortisone—atopic dermatitis	3.46e-05	0.000162	CcSEcCtD
Venlafaxine—Body temperature increased—Hydrocortisone—atopic dermatitis	3.46e-05	0.000162	CcSEcCtD
Venlafaxine—Convulsion—Prednisone—atopic dermatitis	3.46e-05	0.000162	CcSEcCtD
Venlafaxine—Hypertension—Prednisone—atopic dermatitis	3.45e-05	0.000162	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—TAC1—atopic dermatitis	3.42e-05	0.00218	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NPS—atopic dermatitis	3.42e-05	0.00218	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.41e-05	0.00016	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.41e-05	0.00016	CcSEcCtD
Venlafaxine—Arthralgia—Prednisone—atopic dermatitis	3.4e-05	0.000159	CcSEcCtD
Venlafaxine—Myalgia—Prednisone—atopic dermatitis	3.4e-05	0.000159	CcSEcCtD
Venlafaxine—Feeling abnormal—Triamcinolone—atopic dermatitis	3.4e-05	0.000159	CcSEcCtD
Venlafaxine—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.39e-05	0.000159	CcSEcCtD
Venlafaxine—Anxiety—Prednisone—atopic dermatitis	3.39e-05	0.000159	CcSEcCtD
Venlafaxine—Insomnia—Betamethasone—atopic dermatitis	3.38e-05	0.000159	CcSEcCtD
Venlafaxine—Insomnia—Dexamethasone—atopic dermatitis	3.38e-05	0.000159	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.37e-05	0.000158	CcSEcCtD
Venlafaxine—Paraesthesia—Betamethasone—atopic dermatitis	3.36e-05	0.000157	CcSEcCtD
Venlafaxine—Paraesthesia—Dexamethasone—atopic dermatitis	3.36e-05	0.000157	CcSEcCtD
Venlafaxine—Discomfort—Prednisone—atopic dermatitis	3.36e-05	0.000157	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCR3—atopic dermatitis	3.35e-05	0.00213	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Prednisolone—atopic dermatitis	3.3e-05	0.000155	CcSEcCtD
Venlafaxine—Dyspepsia—Dexamethasone—atopic dermatitis	3.29e-05	0.000154	CcSEcCtD
Venlafaxine—Dyspepsia—Betamethasone—atopic dermatitis	3.29e-05	0.000154	CcSEcCtD
Venlafaxine—Urticaria—Triamcinolone—atopic dermatitis	3.28e-05	0.000153	CcSEcCtD
Venlafaxine—Urticaria—Methylprednisolone—atopic dermatitis	3.27e-05	0.000153	CcSEcCtD
Venlafaxine—Body temperature increased—Triamcinolone—atopic dermatitis	3.26e-05	0.000153	CcSEcCtD
Venlafaxine—Oedema—Prednisone—atopic dermatitis	3.26e-05	0.000153	CcSEcCtD
Venlafaxine—Anaphylactic shock—Prednisone—atopic dermatitis	3.26e-05	0.000153	CcSEcCtD
Venlafaxine—Abdominal pain—Methylprednisolone—atopic dermatitis	3.25e-05	0.000152	CcSEcCtD
Venlafaxine—Decreased appetite—Betamethasone—atopic dermatitis	3.25e-05	0.000152	CcSEcCtD
Venlafaxine—Decreased appetite—Dexamethasone—atopic dermatitis	3.25e-05	0.000152	CcSEcCtD
Venlafaxine—Infection—Prednisone—atopic dermatitis	3.24e-05	0.000152	CcSEcCtD
Venlafaxine—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.23e-05	0.000151	CcSEcCtD
Venlafaxine—Fatigue—Dexamethasone—atopic dermatitis	3.23e-05	0.000151	CcSEcCtD
Venlafaxine—Fatigue—Betamethasone—atopic dermatitis	3.23e-05	0.000151	CcSEcCtD
Venlafaxine—Shock—Prednisone—atopic dermatitis	3.21e-05	0.00015	CcSEcCtD
Venlafaxine—Pain—Dexamethasone—atopic dermatitis	3.2e-05	0.00015	CcSEcCtD
Venlafaxine—Pain—Betamethasone—atopic dermatitis	3.2e-05	0.00015	CcSEcCtD
Venlafaxine—Tachycardia—Prednisone—atopic dermatitis	3.18e-05	0.000149	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—IL5—atopic dermatitis	3.18e-05	0.00202	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.17e-05	0.00202	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Prednisone—atopic dermatitis	3.15e-05	0.000148	CcSEcCtD
Venlafaxine—Asthenia—Hydrocortisone—atopic dermatitis	3.14e-05	0.000147	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	3.11e-05	0.00198	CbGpPWpGaD
Venlafaxine—Anorexia—Prednisone—atopic dermatitis	3.11e-05	0.000146	CcSEcCtD
Venlafaxine—Pruritus—Hydrocortisone—atopic dermatitis	3.1e-05	0.000145	CcSEcCtD
Venlafaxine—Feeling abnormal—Betamethasone—atopic dermatitis	3.08e-05	0.000144	CcSEcCtD
Venlafaxine—Feeling abnormal—Dexamethasone—atopic dermatitis	3.08e-05	0.000144	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.06e-05	0.000143	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.06e-05	0.000143	CcSEcCtD
Venlafaxine—Hypersensitivity—Triamcinolone—atopic dermatitis	3.04e-05	0.000142	CcSEcCtD
Venlafaxine—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.03e-05	0.000142	CcSEcCtD
Venlafaxine—Diarrhoea—Hydrocortisone—atopic dermatitis	3e-05	0.00014	CcSEcCtD
Venlafaxine—Urticaria—Betamethasone—atopic dermatitis	2.97e-05	0.000139	CcSEcCtD
Venlafaxine—Urticaria—Dexamethasone—atopic dermatitis	2.97e-05	0.000139	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	2.97e-05	0.000139	CcSEcCtD
Venlafaxine—Dizziness—Prednisolone—atopic dermatitis	2.97e-05	0.000139	CcSEcCtD
Venlafaxine—Asthenia—Triamcinolone—atopic dermatitis	2.96e-05	0.000139	CcSEcCtD
Venlafaxine—Body temperature increased—Betamethasone—atopic dermatitis	2.96e-05	0.000139	CcSEcCtD
Venlafaxine—Abdominal pain—Betamethasone—atopic dermatitis	2.96e-05	0.000139	CcSEcCtD
Venlafaxine—Abdominal pain—Dexamethasone—atopic dermatitis	2.96e-05	0.000139	CcSEcCtD
Venlafaxine—Body temperature increased—Dexamethasone—atopic dermatitis	2.96e-05	0.000139	CcSEcCtD
Venlafaxine—Asthenia—Methylprednisolone—atopic dermatitis	2.95e-05	0.000138	CcSEcCtD
Venlafaxine—Insomnia—Prednisone—atopic dermatitis	2.95e-05	0.000138	CcSEcCtD
Venlafaxine—Paraesthesia—Prednisone—atopic dermatitis	2.93e-05	0.000137	CcSEcCtD
Venlafaxine—Pruritus—Triamcinolone—atopic dermatitis	2.92e-05	0.000137	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.92e-05	0.00186	CbGpPWpGaD
Venlafaxine—Pruritus—Methylprednisolone—atopic dermatitis	2.91e-05	0.000136	CcSEcCtD
Venlafaxine—Dizziness—Hydrocortisone—atopic dermatitis	2.9e-05	0.000136	CcSEcCtD
Venlafaxine—Dyspepsia—Prednisone—atopic dermatitis	2.87e-05	0.000134	CcSEcCtD
Venlafaxine—Decreased appetite—Prednisone—atopic dermatitis	2.83e-05	0.000133	CcSEcCtD
Venlafaxine—Rash—Prednisolone—atopic dermatitis	2.83e-05	0.000132	CcSEcCtD
Venlafaxine—Dermatitis—Prednisolone—atopic dermatitis	2.83e-05	0.000132	CcSEcCtD
Venlafaxine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.82e-05	0.000132	CcSEcCtD
Venlafaxine—Fatigue—Prednisone—atopic dermatitis	2.81e-05	0.000132	CcSEcCtD
Venlafaxine—Headache—Prednisolone—atopic dermatitis	2.81e-05	0.000132	CcSEcCtD
Venlafaxine—Constipation—Prednisone—atopic dermatitis	2.79e-05	0.000131	CcSEcCtD
Venlafaxine—Vomiting—Hydrocortisone—atopic dermatitis	2.79e-05	0.00013	CcSEcCtD
Venlafaxine—Rash—Hydrocortisone—atopic dermatitis	2.76e-05	0.000129	CcSEcCtD
Venlafaxine—Dermatitis—Hydrocortisone—atopic dermatitis	2.76e-05	0.000129	CcSEcCtD
Venlafaxine—Headache—Hydrocortisone—atopic dermatitis	2.74e-05	0.000129	CcSEcCtD
Venlafaxine—Dizziness—Triamcinolone—atopic dermatitis	2.73e-05	0.000128	CcSEcCtD
Venlafaxine—Dizziness—Methylprednisolone—atopic dermatitis	2.72e-05	0.000127	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CXCL10—atopic dermatitis	2.71e-05	0.00173	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—atopic dermatitis	2.71e-05	0.00172	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Prednisone—atopic dermatitis	2.69e-05	0.000126	CcSEcCtD
Venlafaxine—Asthenia—Dexamethasone—atopic dermatitis	2.69e-05	0.000126	CcSEcCtD
Venlafaxine—Asthenia—Betamethasone—atopic dermatitis	2.69e-05	0.000126	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.67e-05	0.000125	CcSEcCtD
Venlafaxine—Nausea—Prednisolone—atopic dermatitis	2.66e-05	0.000125	CcSEcCtD
Venlafaxine—Pruritus—Dexamethasone—atopic dermatitis	2.65e-05	0.000124	CcSEcCtD
Venlafaxine—Pruritus—Betamethasone—atopic dermatitis	2.65e-05	0.000124	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	2.64e-05	0.00168	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.62e-05	0.00167	CbGpPWpGaD
Venlafaxine—Vomiting—Triamcinolone—atopic dermatitis	2.62e-05	0.000123	CcSEcCtD
Venlafaxine—Vomiting—Methylprednisolone—atopic dermatitis	2.62e-05	0.000123	CcSEcCtD
Venlafaxine—Nausea—Hydrocortisone—atopic dermatitis	2.6e-05	0.000122	CcSEcCtD
Venlafaxine—Rash—Triamcinolone—atopic dermatitis	2.6e-05	0.000122	CcSEcCtD
Venlafaxine—Dermatitis—Triamcinolone—atopic dermatitis	2.6e-05	0.000122	CcSEcCtD
Venlafaxine—Rash—Methylprednisolone—atopic dermatitis	2.59e-05	0.000122	CcSEcCtD
Venlafaxine—Dermatitis—Methylprednisolone—atopic dermatitis	2.59e-05	0.000121	CcSEcCtD
Venlafaxine—Urticaria—Prednisone—atopic dermatitis	2.59e-05	0.000121	CcSEcCtD
Venlafaxine—Headache—Triamcinolone—atopic dermatitis	2.58e-05	0.000121	CcSEcCtD
Venlafaxine—Headache—Methylprednisolone—atopic dermatitis	2.58e-05	0.000121	CcSEcCtD
Venlafaxine—Abdominal pain—Prednisone—atopic dermatitis	2.58e-05	0.000121	CcSEcCtD
Venlafaxine—Body temperature increased—Prednisone—atopic dermatitis	2.58e-05	0.000121	CcSEcCtD
Venlafaxine—Diarrhoea—Dexamethasone—atopic dermatitis	2.56e-05	0.00012	CcSEcCtD
Venlafaxine—Diarrhoea—Betamethasone—atopic dermatitis	2.56e-05	0.00012	CcSEcCtD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.54e-05	0.00161	CbGpPWpGaD
Venlafaxine—Dizziness—Betamethasone—atopic dermatitis	2.47e-05	0.000116	CcSEcCtD
Venlafaxine—Dizziness—Dexamethasone—atopic dermatitis	2.47e-05	0.000116	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	2.46e-05	0.00156	CbGpPWpGaD
Venlafaxine—Nausea—Triamcinolone—atopic dermatitis	2.45e-05	0.000115	CcSEcCtD
Venlafaxine—Nausea—Methylprednisolone—atopic dermatitis	2.44e-05	0.000115	CcSEcCtD
Venlafaxine—Hypersensitivity—Prednisone—atopic dermatitis	2.4e-05	0.000112	CcSEcCtD
Venlafaxine—Vomiting—Dexamethasone—atopic dermatitis	2.38e-05	0.000111	CcSEcCtD
Venlafaxine—Vomiting—Betamethasone—atopic dermatitis	2.38e-05	0.000111	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL8—atopic dermatitis	2.37e-05	0.00151	CbGpPWpGaD
Venlafaxine—Rash—Dexamethasone—atopic dermatitis	2.36e-05	0.000111	CcSEcCtD
Venlafaxine—Rash—Betamethasone—atopic dermatitis	2.36e-05	0.000111	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	2.36e-05	0.0015	CbGpPWpGaD
Venlafaxine—Dermatitis—Betamethasone—atopic dermatitis	2.36e-05	0.00011	CcSEcCtD
Venlafaxine—Dermatitis—Dexamethasone—atopic dermatitis	2.36e-05	0.00011	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	2.35e-05	0.00149	CbGpPWpGaD
Venlafaxine—Headache—Dexamethasone—atopic dermatitis	2.34e-05	0.00011	CcSEcCtD
Venlafaxine—Headache—Betamethasone—atopic dermatitis	2.34e-05	0.00011	CcSEcCtD
Venlafaxine—Asthenia—Prednisone—atopic dermatitis	2.34e-05	0.00011	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CCL5—atopic dermatitis	2.33e-05	0.00148	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	2.32e-05	0.00148	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.31e-05	0.00147	CbGpPWpGaD
Venlafaxine—Pruritus—Prednisone—atopic dermatitis	2.31e-05	0.000108	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—IL2—atopic dermatitis	2.27e-05	0.00144	CbGpPWpGaD
Venlafaxine—Diarrhoea—Prednisone—atopic dermatitis	2.23e-05	0.000104	CcSEcCtD
Venlafaxine—Nausea—Betamethasone—atopic dermatitis	2.22e-05	0.000104	CcSEcCtD
Venlafaxine—Nausea—Dexamethasone—atopic dermatitis	2.22e-05	0.000104	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NGF—atopic dermatitis	2.16e-05	0.00138	CbGpPWpGaD
Venlafaxine—Dizziness—Prednisone—atopic dermatitis	2.16e-05	0.000101	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—atopic dermatitis	2.15e-05	0.00137	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—atopic dermatitis	2.12e-05	0.00135	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCR5—atopic dermatitis	2.1e-05	0.00134	CbGpPWpGaD
Venlafaxine—Vomiting—Prednisone—atopic dermatitis	2.07e-05	9.71e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—IL2—atopic dermatitis	2.06e-05	0.00131	CbGpPWpGaD
Venlafaxine—Rash—Prednisone—atopic dermatitis	2.05e-05	9.63e-05	CcSEcCtD
Venlafaxine—Dermatitis—Prednisone—atopic dermatitis	2.05e-05	9.62e-05	CcSEcCtD
Venlafaxine—Headache—Prednisone—atopic dermatitis	2.04e-05	9.56e-05	CcSEcCtD
Venlafaxine—ABCG2—Metabolism—GLB1—atopic dermatitis	2.04e-05	0.0013	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ADSL—atopic dermatitis	1.96e-05	0.00124	CbGpPWpGaD
Venlafaxine—Nausea—Prednisone—atopic dermatitis	1.94e-05	9.07e-05	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NFKBIA—atopic dermatitis	1.78e-05	0.00113	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.73e-05	0.0011	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—IL6—atopic dermatitis	1.73e-05	0.0011	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.71e-05	0.00109	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.7e-05	0.00108	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.58e-05	0.001	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.54e-05	0.000978	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.53e-05	0.000976	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GLB1—atopic dermatitis	1.49e-05	0.000951	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ADSL—atopic dermatitis	1.43e-05	0.000912	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.41e-05	0.000899	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—atopic dermatitis	1.27e-05	0.000809	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL2—atopic dermatitis	1.22e-05	0.000773	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—IL6—atopic dermatitis	1.21e-05	0.000769	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.13e-05	0.000719	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MAPK8—atopic dermatitis	1.12e-05	0.000711	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GLB1—atopic dermatitis	1.1e-05	0.000701	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.08e-05	0.000689	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.07e-05	0.000679	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADSL—atopic dermatitis	1.06e-05	0.000672	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.04e-05	0.000661	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.03e-05	0.000655	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADSL—atopic dermatitis	9.96e-06	0.000634	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADSL—atopic dermatitis	9.88e-06	0.000628	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	8.45e-06	0.000537	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.23e-06	0.000524	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	7.64e-06	0.000486	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.51e-06	0.000478	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IL6—atopic dermatitis	7.14e-06	0.000454	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GLB1—atopic dermatitis	6.79e-06	0.000432	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPARA—atopic dermatitis	6.62e-06	0.000421	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADSL—atopic dermatitis	6.51e-06	0.000414	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPARA—atopic dermatitis	4.85e-06	0.000309	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPARA—atopic dermatitis	3.67e-06	0.000233	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPARA—atopic dermatitis	3.58e-06	0.000228	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPARA—atopic dermatitis	3.37e-06	0.000215	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.34e-06	0.000213	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.2e-06	0.00014	CbGpPWpGaD
